Excelsior raises $95 million to rethink small-molecule chemistry for the AI era By reengineering small-molecule chemistry for automation, Excelsior aims to remove a long-standing barrier to AI-driven drug discovery.

https://www.drugdiscoverynews.com/excelcsior-raises-95-million-to-rethink-small-molecule-chemistry-for-the-ai-era-16916